Skip to main navigation
Skip to content
Top Bar
  • Careers
  • Contact Us
Cyclacel Pharmaceuticals, Inc.
Header Nav - Desktop
  • About Us
    • LEADERSHIP
    • BOARD OF DIRECTORS
  • Our Science
    • OVERVIEW
    • FADRACICLIB
    • CYC140
    • SAPACITABINE
    • Publications
  • Pipeline
  • News
  • Investors
Cyclacel Pharmaceuticals, Inc.

Investors

Overview

Investor Relations
  • Investor Relations
  • News Releases
  • Presentations & Events
  • Common Stock Information
    • Stock Quote & Chart
    • Analyst Coverage
  • SEC Filings
  • Corporate Governance
    • Overview
    • Board of Directors
    • Committee Composition
    • Management Team
  • Corporate Factsheet
  • Annual Reports

Overview

FRONT >> Quick Links
Stock Info
News Releases
SEC Filings
Analyst Coverage
Presentations & Events
Corporate Factsheet

News Releases

May 11 2022
Cyclacel Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Business Update
May 04 2022
Cyclacel Pharmaceuticals to Release First Quarter 2022 Financial Results
Apr 19 2022
Cyclacel Announces Dosing of First Patient in Phase 1/2 Study of Oral Cyc140 in Patients With Advanced Solid Tumors and Lymphomas
FRONT >> News > View All View All News

Events

May 11 2022 at 4:30 PM EDT
First Quarter 2022 Financial Results
Mar 28 2022 at 4:30 PM EDT
Fourth Quarter 2021 Financial Results
Jan 10 2022
Biotech Showcase 2022 Virtual Conference
FRONT > Events - View All View All Events

Featured Videos

CEO Spiro Rombotis addressing Cancer Resistance
CEO Spiro Rombotis addressing Cancer Resistance
Toolkit
Email AlertsRSS FeedsPrint Page
Header Nav - Mobile
  • About Us
    • LEADERSHIP
    • BOARD OF DIRECTORS
  • Our Science
    • OVERVIEW
    • FADRACICLIB
    • CYC140
    • SAPACITABINE
    • Publications
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact Us
  • Accessibility Statement
  • Privacy Policy
  • Disclaimer
  • Sitemap
Header Nav - Mobile
  • About Us
    • LEADERSHIP
    • BOARD OF DIRECTORS
  • Our Science
    • OVERVIEW
    • FADRACICLIB
    • CYC140
    • SAPACITABINE
    • Publications
  • Pipeline
  • News
  • Investors
  • Careers
  • Contact Us
  • Accessibility Statement
  • Privacy Policy
  • Disclaimer
  • Sitemap
Cyclacel Pharmaceuticals, Inc. logo

200 Connell Drive #1500
Berkeley Heights, NJ 07922
United States of America

  • E: info@cyclacel.com
  • T: +1 (908) 517 7330
  • F: +1 (866) 271 3466

Sign up for email alerts ยป

Footer Social
  • Twitter
  • LinkedIn
Footer Links
  • Accessibility Statement
  • Privacy Policy
  • Disclaimer
  • Sitemap

© 2022 Cyclacel Pharmaceuticals, Inc.